HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Viktor H Koelzer Selected Research
Viktor H Koelzer Research Topics
Disease
30
Neoplasms (Cancer)
01/2022 - 06/2009
15
Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2014
5
Melanoma (Melanoma, Malignant)
09/2018 - 01/2010
3
Lymphatic Metastasis
01/2018 - 07/2014
3
Neoplasm Metastasis (Metastasis)
08/2015 - 07/2014
2
Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 01/2021
2
Tertiary Lymphoid Structures
01/2022 - 01/2018
2
Rectal Neoplasms (Rectal Cancer)
12/2021 - 01/2016
2
Microsatellite Instability
01/2021 - 01/2016
2
Pneumonia (Pneumonitis)
01/2018 - 01/2016
2
Virus Diseases (Viral Diseases)
01/2018 - 01/2014
2
Disease Progression
01/2016 - 07/2014
2
Inflammation (Inflammations)
01/2016 - 01/2016
1
Liver Neoplasms (Liver Cancer)
01/2022
1
Hepatocellular Carcinoma (Hepatoma)
01/2022
1
Prostatic Neoplasms (Prostate Cancer)
01/2022
1
Breast Neoplasms (Breast Cancer)
01/2021
1
Esophageal Neoplasms (Esophageal Cancer)
01/2021
1
COVID-19
10/2020
1
Lung Diseases (Lung Disease)
10/2020
1
Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2020
1
Ataxia (Dyssynergia)
01/2018
1
Grover's disease
01/2016
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016
1
Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
01/2016
1
Drug Eruptions (Drug Eruption)
01/2016
1
Polyps
01/2016
1
Pruritus (Itching)
01/2016
1
Skin Diseases (Skin Disease)
01/2016
1
Sarcoma (Soft Tissue Sarcoma)
08/2015
1
Colonic Neoplasms (Colon Cancer)
03/2015
1
Adenoma (Adenomas)
07/2014
1
Carcinoma (Carcinomatosis)
07/2014
1
Malignant Fibrous Histiocytoma
07/2014
Drug/Important Bio-Agent (IBA)
10
Biomarkers (Surrogate Marker)
IBA
01/2021 - 04/2013
6
Proteins (Proteins, Gene)
FDA Link
01/2020 - 05/2014
5
Immune Checkpoint Inhibitors
IBA
01/2022 - 01/2016
4
Ligands
IBA
01/2020 - 01/2014
4
Keratins (Keratin)
IBA
07/2017 - 05/2015
4
Indicators and Reagents (Reagents)
IBA
01/2016 - 01/2014
3
RNA (Ribonucleic Acid)
IBA
01/2022 - 01/2010
3
Biological Products
IBA
01/2022 - 01/2021
3
Cytokines
IBA
01/2018 - 07/2014
3
Ipilimumab
IBA
01/2018 - 01/2016
2
MicroRNAs (MicroRNA)
IBA
01/2022 - 01/2017
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2022 - 01/2018
2
Complement System Proteins (Complement)
IBA
01/2022 - 05/2015
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2021 - 01/2016
2
Uncoupling Protein 2
IBA
04/2019 - 01/2019
2
Programmed Cell Death 1 Receptor
IBA
01/2018 - 01/2016
2
Calcibiotic Root Canal Sealer
IBA
01/2016 - 03/2015
1
Phosphotransferases (Kinase)
IBA
01/2022
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
01/2022
1
Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)
IBA
01/2022
1
Chemokines
IBA
01/2021
1
DNA (Deoxyribonucleic Acid)
IBA
01/2021
1
Platinum
IBA
01/2021
1
Catenins
IBA
01/2020
1
B7-H1 Antigen
IBA
09/2018
1
Antigens
IBA
01/2018
1
Antibodies
IBA
01/2018
1
Interferons
IBA
01/2017
1
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
01/2017
1
Fluorouracil (Carac)
FDA Link
Generic
01/2017
1
DNA Polymerase II
IBA
11/2016
1
Interleukin-33
IBA
01/2016
1
Bevacizumab (Avastin)
FDA Link
01/2016
1
Capecitabine (Xeloda)
FDA Link
01/2016
1
Irinotecan (Camptosar)
FDA Link
Generic
01/2016
1
Nivolumab
IBA
01/2016
1
Bleomycin (Blenoxane)
FDA Link
Generic
01/2016
1
Cisplatin (Platino)
FDA Link
Generic
01/2016
1
Pharmaceutical Preparations
IBA
01/2016
1
Etoposide (VP 16)
FDA Link
Generic
01/2016
1
Interleukins
IBA
01/2016
1
Chemokine CCL22
IBA
11/2015
1
Interferon Type I
IBA
11/2015
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
11/2015
1
tapasin
IBA
08/2015
1
RNA-Binding Proteins (RNA-Binding Protein)
IBA
08/2015
1
I-antigen
IBA
08/2015
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
08/2015
1
Hematoxylin (Haematoxylon)
IBA
05/2015
1
Eosine Yellowish-(YS) (Eosin)
IBA
05/2015
1
antineoplaston A10 (A 10)
IBA
05/2015
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
04/2015
1
Cadherins (E-Cadherin)
IBA
01/2015
1
Interleukin-23 (Interleukin 23)
IBA
07/2014
1
Interleukin-23 Subunit p19
IBA
07/2014
1
tocilizumab (atlizumab)
FDA Link
07/2014
1
CDX2 Transcription Factor
IBA
05/2014
1
Paraffin
IBA
01/2014
1
Conditioned Culture Media
IBA
01/2014
Therapy/Procedure
8
Therapeutics
01/2019 - 11/2011
5
Immunotherapy
01/2022 - 06/2009
2
Lasers (Laser)
01/2022 - 01/2015
2
Drug Therapy (Chemotherapy)
01/2021 - 01/2017
1
Radiotherapy
12/2021
1
Precision Medicine
01/2021
1
Neoadjuvant Therapy
01/2016